"stage I: one node or group of adjacent nodes"
"stage II: two or more nodal groups, same side of the diaphragm"
"stage III: nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement"
"stage III(1): involvement of the spleen or splenic, hilar, coeliac, or portal nodes"
"stage III(2): involvement of the para-aortic, iliac, inguinal, or mesenteric nodes"
"stage IV: diffuse or disseminated involvement of one or more extranodal organs or tissue beyond that designated E, with or without associated lymph node involvement"
"anatomic description of disease extent: previously Ann Arbor stage I or II are now categorised as having “limited” disease and previously Ann Arbor stage III or IV are now categorised as having “advanced” disease"
"stage IIE: contiguous extra-lymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm."
"stage IE: single extra-lymphatic site in the absence of nodal involvement"
"stage IIE: contiguous extra-lymphatic extension from a nodal site with or without involvement of other lymph node regions on the same side of the diaphragm."
"The goal was to simplify and standardise the response assessment enabling better understanding and communication among professionals. The Lugano staging system has an excellent inter-observer agreement in staging (k=0.90, percent agreement=94.9%) and treatment response assessment (k=0.91, percent agreement=95.8%) 3."
"all cases to indicate the absence (A) or presence (B) of systemic symptoms (fever/night sweats/unexplained weight loss)"
"all cases to indicate the absence (A) or presence (B) of systemic symptoms (fever/night sweats/unexplained weight loss)"
"designation of (E) refers to extranodal contiguous extension that can still be encompassed within a irradiation field appropriate for nodal disease of the same anatomic extent (if more extensive than that, label as IV)"
"designation of (E) refers to extranodal contiguous extension that can still be encompassed within a irradiation field appropriate for nodal disease of the same anatomic extent (if more extensive than that, label as IV)"
"The goal was to simplify and standardise the response assessment enabling better understanding and communication among professionals. The Lugano staging system has an excellent inter-observer agreement in staging (k=0.90, percent agreement=94.9%) and treatment response assessment (k=0.91, percent agreement=95.8%) 3."
Expected headings
"Limited"
"Advanced"
"Changes from previous versions"
"stage III: nodes on both sides of the diaphragm; nodes above the diaphragm with spleen involvement"
"stage IV: diffuse or disseminated involvement of one or more extranodal organs or tissue beyond that designated E, with or without associated lymph node involvement"